103 related articles for article (PubMed ID: 3377783)
1. Dexamethasone inhibits the cytotoxic activity of tumor necrosis factor.
Tsujimoto M; Okamura N; Adachi H
Biochem Biophys Res Commun; 1988 May; 153(1):109-15. PubMed ID: 3377783
[TBL] [Abstract][Full Text] [Related]
2. Cellular stress and glucocorticoid hormones protect L929 mouse fibroblasts from tumor necrosis factor alpha cytotoxicity.
Pagliacci MC; Migliorati G; Smacchia M; Grignani F; Riccardi C; Nicoletti I
J Endocrinol Invest; 1993 Sep; 16(8):591-9. PubMed ID: 8258647
[TBL] [Abstract][Full Text] [Related]
3. Modulation of mitogenic activity of tumor necrosis factor by interferons and dexamethasone.
Tsujimoto M; Sugiyama M; Adachi H
Lymphokine Res; 1989; 8(2):99-106. PubMed ID: 2499736
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells.
Kurokouchi K; Kambe F; Kikumori T; Sakai T; Sarkar D; Ishiguro N; Iwata H; Seo H
J Bone Miner Res; 2000 Sep; 15(9):1707-15. PubMed ID: 10976991
[TBL] [Abstract][Full Text] [Related]
5. Effects of steroid hormones on the cytotoxic activity of tumor necrosis factor.
Tsujimoto M; Adachi H
J Biochem; 1988 Mar; 103(3):393-5. PubMed ID: 3391991
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
[TBL] [Abstract][Full Text] [Related]
7. The role of iron in the cytotoxicity of tumor necrosis factor.
Warren S; Torti SV; Torti FM
Lymphokine Cytokine Res; 1993 Apr; 12(2):75-80. PubMed ID: 8324080
[TBL] [Abstract][Full Text] [Related]
8. TNF-mediated IL6 gene expression and cytotoxicity are co-inducible in TNF-resistant L929 cells.
Vandevoorde V; Haegeman G; Fiers W
FEBS Lett; 1992 May; 302(3):235-8. PubMed ID: 1318227
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide and tumor necrosis factor stimulate lung microvascular arginine uptake, a response attenuated by dexamethasone.
Pan M; Wasa M; Ryan U; Souba W
JPEN J Parenter Enteral Nutr; 1996; 20(1):50-5. PubMed ID: 8788263
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation.
Palombella VJ; Vilcek J
J Biol Chem; 1989 Oct; 264(30):18128-36. PubMed ID: 2808369
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement.
Beyaert R; Suffys P; Van Roy F; Fiers W
FEBS Lett; 1990 Mar; 262(1):93-6. PubMed ID: 2138568
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.
Machuca C; Mendoza-Milla C; Córdova E; Mejía S; Covarrubias L; Ventura J; Zentella A
BMC Cell Biol; 2006 Feb; 7():9. PubMed ID: 16504042
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha.
Han CW; Choi JH; Kim JM; Kim WY; Lee KY; Oh GT
Rheumatology (Oxford); 2001 Mar; 40(3):267-73. PubMed ID: 11285373
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-alpha.
Yamamoto Y; Ishizu A; Ikeda H; Otsuka N; Yoshiki T
Pathobiology; 2004; 71(6):295-301. PubMed ID: 15627839
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB activation but not PI3K/Akt is required for dexamethasone dependent protection against TNF-alpha cytotoxicity in L929 cells.
Mendoza-Milla C; Machuca Rodríguez C; Córdova Alarcón E; Estrada Bernal A; Toledo-Cuevas EM; Martínez Martínez E; Zentella Dehesa A
FEBS Lett; 2005 Jul; 579(18):3947-52. PubMed ID: 16000198
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation.
Hammer S; Sauer B; Spika I; Schraut C; Kleuser B; Schäfer-Korting M
J Cell Biochem; 2004 Mar; 91(4):840-51. PubMed ID: 14991774
[TBL] [Abstract][Full Text] [Related]
17. A possible role of glucocorticoids: an intrinsic inhibitor of the cytotoxic activity of tumor necrosis factor.
Abe S; Yamamoto T; Iihara S; Yamazaki M; Mizuno D
Jpn J Cancer Res; 1988 Mar; 79(3):305-8. PubMed ID: 3131280
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts.
Kohase M; Henriksen-Destefano D; Sehgal PB; Vilcek J
J Cell Physiol; 1987 Aug; 132(2):271-8. PubMed ID: 3040777
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance.
Wu YL; Jiang XR; Lillington DM; Newland AC; Kelsey SM
Br J Haematol; 2000 Dec; 111(3):807-16. PubMed ID: 11122142
[TBL] [Abstract][Full Text] [Related]
20. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression.
Remick DG; Strieter RM; Lynch JP; Nguyen D; Eskandari M; Kunkel SL
Lab Invest; 1989 Jun; 60(6):766-71. PubMed ID: 2733382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
